<DOC>
	<DOCNO>NCT01877564</DOCNO>
	<brief_summary>The purpose research determine effect Metformin , well tolerate drug widely prescribe treatment Type 2 Diabetes Mellitus , endometrium cancer patient .</brief_summary>
	<brief_title>A Randomized Pilot Study Evaluate Effects Short Course Metformin Versus No Therapy Period Prior Hysterectomy Grade 1-2 Adenocarcinoma Endometrium Obese Non-Diabetic Women</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Histological confirm diagnosis grade I II adenocarcinoma endometrium Must obese define body mass index ( BMI ) great equal 30 kg/m2 Candidate surgical removal uterus part endometrial cancer treatment Subjects must sign informed consent Age 42 65 year age Electrocorticogram ( ECOG ) Performance status 0 2 History adequate renal , liver , bone marrow function : Hb : ( adequate surgical intervention , transfusion necessary ) White Blood Cell ( WBC ) : ( normal range ) Platelets : ( 180K/cmm ) Liver Function Test ( LFTs ) : Normal bilirubin ( &lt; 2.0mg/dL ) , AST/ALT ( 2xULN ) Renal function : creatinine le 1.4 Female subject must either childbearing potential must negative urine pregnancy test within 7 day randomization Metformin . Subjects consider childbearing potential surgically sterile postmenopausal great 12 month . Poorly differentiated cancer highrisk subtypes endometrial cancer include serous , clear cell , carcinosarcoma History diabetes mellitus Type 1 Type 2 . Receiving metformin prior enrollment Known hypersensitivity metformin . Unable swallow retain oral medication . Pregnant lactating . Previous concurrent malignancy , except nonmelanoma skin cancer , unless curatively treat evidence recurrence &gt; 5 year If physician feel candidate suitable study , he/she exclude . Currently take biguanides , sulfonylurea drug , thiazolidinediones , insulin , mTOR DPP4 inhibitor take medication 12 week prior study participation . Clinical symptom gastrointestinal obstruction bleed consideration immediate surgery immediate neoadjuvant chemoradiation . History lactic metabolic acidosis . Uncontrolled infectious disease . History positivity human immunodeficiency virus ( HIV ) . History congestive heart failure require pharmacologic treatment . History excessive alcohol abuse , define habitual intake three drink daily . Malabsorption syndrome , disease affect gastrointestinal function , previous resection stomach small bowel . Current use medication weight loss . Currently take cimetidine , thiazide diuretic cephalexin . If patient need agent , alternative agent substitute .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>